Neuronetics Inc Total Liabilities

Latest as of March 2026: $108.38 Million USD

Neuronetics Inc total liabilities. Based on the latest financial reports, Neuronetics Inc (STIM) has total liabilities worth $108.38 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check STIM cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Neuronetics Inc (2016–2025)

Total liabilities of Neuronetics Inc from 2016 to 2025. This chart illustrates how Neuronetics Inc's total liabilities have evolved over time, based on quarterly financial data. Explore Neuronetics Inc long-term investment intensity to see how much of total assets are deployed in long-term investments.

Neuronetics Inc Competitors by Total Liabilities

The table below lists competitors of Neuronetics Inc ranked by their total liabilities.

Company	Country	Total Liabilities
TAT HONG EQ.SRV. DL-08 F:1Q2	Germany	€1.70 Billion
OBOOK Holdings Inc. Class A Common Shares NASDAQ:OWLS	USA	$30.60 Million
Sao Ta Foods JSC VN:FMC	Vietnam	₫1.79 Trillion
Shree Digvijay Cement Co.Ltd NSE:SHREDIGCEM	India	Rs6.93 Billion
PJBumi Bhd KLSE:7163	Malaysia	RM45.39 Million
Empress Royalty Corp V:EMPR	Canada	CA$7.23 Million
Arla Plast AB ST:ARPL	Sweden	Skr350.90 Million
Polaryx Therapeutics, Inc. Common Stock NASDAQ:PLYX	USA	$873.00K

Liability Composition Analysis (2016–2025)

This chart breaks down Neuronetics Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Neuronetics Inc asset portfolio.

Liquidity & Leverage Metrics

Neuronetics Inc Total Liabilities Ratios Explained

Neuronetics Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	1.67	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	8.17	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.86	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Neuronetics Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Neuronetics Inc (2016–2025)

The table below shows the annual total liabilities of Neuronetics Inc from 2016 to 2025.

Year	Total Liabilities	Change
2025-12-31	$115.31 Million	+5.69%
2024-12-31	$109.10 Million	+33.64%
2023-12-31	$81.64 Million	+36.47%
2022-12-31	$59.82 Million	+6.74%
2021-12-31	$56.05 Million	+5.42%
2020-12-31	$53.16 Million	+1.62%
2019-12-31	$52.32 Million	+13.78%
2018-12-31	$45.98 Million	-80.15%
2017-12-31	$231.59 Million	+14.69%
2016-12-31	$201.92 Million	--

About Neuronetics Inc

NASDAQ:STIM USA Medical Devices

Market Cap

$157.27 Million

Market Cap Rank

#19556 Global

#4497 in USA

Share Price

$2.26

Change (1 day)

+9.71%

52-Week Range

$1.18 - $3.30

All Time High

$37.54